Copy in clipboard...
Iran makes significant progress in reducing medicine shortages
Heider Mohammadi attributed the improvement to easier access to foreign currency and smoother supply chain operations this year, ILNA reported.
He emphasized that ensuring a steady supply of medicines, and medical equipment on sufficient and stable access to foreign currency and liquidity.
When asked about the availability of psychiatric medications, Mohammadi assured that there are no shortages in this area, as most of these drugs are produced domestically.
He acknowledged that some patients with psychiatric conditions, prefer imported brands, and accommodations are made for such cases.
He expressed hope that the instructions from the Central Bank will be implemented by the banks, as the lack of credit and liquidity remains the most significant challenge facing pharmaceutical companies.
On the topic of the quality of domestically produced medicines, Mohammadi refuted the notion that they fall short of the required standards.
He highlighted that 99% of the Iranian pharmaceutical market comprises locally produced drugs, which are used by the population.
Mohammadi emphasized that these medicines are manufactured according to global standards and are compared to branded drugs for efficacy.
He added that special considerations are made for patients with specific conditions who may require imported medications due to compatibility issues.